Drug intelligence / Profile preview

Ovalbumin (Gal d 2)

Development stage
Unknown
Modality
Recombinant Proteins and Enzymes
Administration
Intraperitoneal, Intranasal, Intragastric, Oral
01

Overview

Gal d 2, also known as ovalbumin, is a major allergenic protein found in chicken egg white, constituting about 54% of its total protein content. It is a phosphorylated glycoprotein with a molecular weight of approximately 44 kDa, comprising 385 amino acids. Gal d 2 belongs to the serpins superfamily. It is considered a primary allergen responsible for IgE-mediated egg allergic reactions, particularly in infants and children. The allergenicity of Gal d 2 is generally associated with uncooked eggs, as heating or enzymatic digestion can reduce its allergenic potential. In the context of allergen-specific immunotherapy, purified Gal d 2 can be administered to individuals with egg allergy to induce immune tolerance and reduce hypersensitivity reactions.

Other names
OvalbuminEgg albuminPlakalbuminGallus domesticus allergen 2Chicken egg white albuminEgg white proteinNatural egg white proteinChicken albuminEgg white extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Ovalbumin (Gal d 2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovalbumin (Gal d 2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call